Yale Cancer Center Smilow Cancer Hospital

EP. 1: Yale Cancer Center Merges Cutting Edge Research with Personalized Medicine

November 21st 2015

EP. 2: Dr. Decker on Pembrolizumab With Concurrent Chemoradiotherapy in Inoperable Locally Advanced NSCLC

April 27th 2021

Roy H. Decker, MD, PhD, discusses the use of pembrolizumab with concurrent chemoradiotherapy in patients with inoperable, locally advanced non–small cell lung cancer.

EP. 3: Dr. Anees Chagpar Named 2021 ASCO Fellow

May 13th 2021

Anees Chagpar, MD, MBA, MPH, FACS, FRCS(C), Professor of Surgery (Oncology) and a member of the Cancer Prevention and Control Research Program at Yale Cancer Center was named a Fellow of the American Society of Clinical Oncology.

EP. 4: Yale Cancer Center’s Dr. Lieping Chen Elected to Prestigious National Academy of Sciences

May 17th 2021

As one of the highest honors in the scientific field, Lieping Chen, MD, PhD, was elected to the National Academy of Sciences

EP. 5: Yale Research to be Presented at 2021 ASCO Annual Meeting

May 28th 2021

Yale Cancer Center and Smilow Cancer Hospital scientists and clinicians are presenting research studies at the 2021 Annual Virtual Meeting of the American Society of Clinical Oncology June 4-8.

EP. 6: Dr. Bewersdorf on the Role of Allogeneic Transplant in Myelofibrosis

June 10th 2021

Jan Philipp Bewersdorf, MD, discusses the role of allogeneic hematopoietic cell transplant in myelofibrosis.

EP. 7: Barbara Burtness Named Interim Associate Director for Diversity, Equity, and Inclusion at Yale Cancer Center

June 30th 2021

Barbara Burtness, MD, has been appointed Interim Associate Director for Diversity, Equity, and Inclusion at Yale Cancer Center.

EP. 8: Joseph W. Kim Receives Prestigious 2021 Cancer Clinical Investigator Team Leadership Award

July 28th 2021

Joseph W. Kim, MD, Associate Professor of Medicine at Yale Cancer Center, has received a 2021 Cancer Clinical Investigator Team Leadership Award from the National Cancer Institute.

EP. 9: Yale Cancer Center Perspective Highlights New Advances for NSCLC

August 18th 2021

A new publication by Yale Cancer Center highlights recent breakthrough therapies developed to treat non-small cell lung cancer.

EP. 10: Yale Cancer Center Study Shows Stem-Like T Cells Could Aid Immunotherapy in Cancer Treatment

September 20th 2021

In a new study by Yale Cancer Center, researchers show stem-like T cells within certain lymph nodes could be natural cancer fighters.

EP. 11: Dr. Silber on the Importance of Improving Clinical Trial Inclusivity in Breast Cancer

September 28th 2021

Andrea L. Silber, MD, discusses the importance of improving clinical trial inclusivity in breast cancer.

EP. 12: Dr. Lustberg Discusses Ongoing Research in Breast Cancer

September 28th 2021

Maryam Lustberg, MD, MPH, discusses ongoing research in breast cancer.

EP. 13: Margaret Gilshannon named Deputy Director for Finance & Administration at Yale Cancer Center

October 18th 2021

Margaret Gilshannon, MHA, has been appointed Deputy Director for Finance & Administration at Yale Cancer Center.

EP. 14: Tissue Mapping Center for Cellular Senescence Launched at Yale Cancer Center to Study Human Lymphoid Organs

October 22nd 2021

The National Institutes of Health has awarded a grant to fund cellular senescence research in lymphoid organs at Yale Cancer Center.

EP. 15: Institutional Perspectives in Cancer- Women’s Cancers: Chaired by Elena Ratner, MD

November 3rd 2021

EP. 16: Eric P. Winer to lead Yale Cancer Center and Smilow Cancer Hospital

November 8th 2021

Eric P. Winer, MD, will be appointed next director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital at Yale New Haven, effective February 1, 2022.

EP. 17: Dr. Parker Discusses the Importance of Optimizing Treatment in Multiple Myeloma

November 10th 2021

Terri Parker, MD, discusses considerations to optimize treatment in multiple myeloma.

EP. 18: Yale Cancer Center Study Shows New Strategy to Boost Immune System to Fight Melanoma

November 15th 2021

Findings from a new study led by Yale Cancer Center researchers shows that the enzyme KDM5B suppresses anti-melanoma immunity, which could help develop a new treatment strategy to benefit patients with melanoma and other cancers.

EP. 19: Dr. Fernandez on the Need to Refine Immunohistochemistry Testing in HER2+ Breast Cancer

December 14th 2021

Aileen I. Fernandez, PhD, discusses the need to refine immunohistochemistry testing in HER2-positive breast cancer.

EP. 20: Dr. Fernandez on the Utility of Trastuzumab Deruxtecan in HER2-Low Breast Cancer

December 22nd 2021

Aileen I. Fernandez, PhD, discusses the utility of fam-trastuzumab deruxtecan-nxki in HER2-low breast cancer.